| Name | tert-butyl 3-(aminomethyl)pyrrolidine-1-carboxylate |
|---|---|
| Synonyms |
(R)-1-Boc-3-(aminomethyl)pyrrolidine
1-Boc-(3-Aminomethyl)pyrrolidine 3-aminomethyl-1-tert-butoxycarbonylpyrrolidine 3-aminomethyl-pyrrolidine-1-carboxylic acid tert-butyl ester 2-Methyl-2-propanyl 3-(aminomethyl)-1-pyrrolidinecarboxylate 1-Boc-3-Aminomrthylpyrrolidine MFCD01861798 3-aminomethyl-1-boc-pyrrolidine 1-Boc-3-(aminomethyl)pyrrolidine tert-Butyl 3-(aminomethyl)pyrrolidine-1-carboxylate |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 280.3±13.0 °C at 760 mmHg |
| Melting Point | 35-36°C |
| Molecular Formula | C10H20N2O2 |
| Molecular Weight | 200.278 |
| Flash Point | 123.3±19.8 °C |
| Exact Mass | 200.152481 |
| PSA | 55.56000 |
| LogP | 0.50 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.486 |
| Storage condition | 2-8°C |
| Symbol |
GHS07, GHS09 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H319-H400 |
| Precautionary Statements | P273-P305 + P351 + P338 |
| Hazard Codes | Xn,N |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36/37/39 |
| RIDADR | UN 3077 9 / PGIII |
| HS Code | 2933990090 |
|
~82%
270912-72-6 |
| Literature: Syntex (U.S.A.) Inc. Patent: US6166015 A1, 2000 ; US 6166015 A |
|
~%
270912-72-6 |
| Literature: GLAXOSMITHKLINE LLC; DOCK, Steven, Thomas; MCSHERRY, Allison, K.; MOORE, Michael, Lee; RIDGERS, Lance, Howard; PARRISH, Cynthia, Ann Patent: WO2013/28445 A1, 2013 ; Location in patent: Page/Page column 50 ; |
|
~%
270912-72-6 |
| Literature: MANNKIND CORPORATION; TOLERO PHARMACEUTICALS, INC.; ZENG, Qingping; FARIS, Mary; MOLLARD, Alexis; WARNER, Steven L.; FLYNN, Gary A. Patent: WO2014/52365 A1, 2014 ; |
|
~%
270912-72-6 |
| Literature: Falgueyret; Oballa; Okamoto; Wesolowski; Aubin; Rydzewski; Prasit; Riendeau; Rodan; Percival Journal of Medicinal Chemistry, 2001 , vol. 44, # 1 p. 94 - 104 |
|
~%
270912-72-6 |
| Literature: Falgueyret; Oballa; Okamoto; Wesolowski; Aubin; Rydzewski; Prasit; Riendeau; Rodan; Percival Journal of Medicinal Chemistry, 2001 , vol. 44, # 1 p. 94 - 104 |
|
~%
270912-72-6 |
| Literature: GLAXOSMITHKLINE LLC; DOCK, Steven, Thomas; MCSHERRY, Allison, K.; MOORE, Michael, Lee; RIDGERS, Lance, Howard; PARRISH, Cynthia, Ann Patent: WO2013/28445 A1, 2013 ; |
|
~%
270912-72-6 |
| Literature: GLAXOSMITHKLINE LLC; DOCK, Steven, Thomas; MCSHERRY, Allison, K.; MOORE, Michael, Lee; RIDGERS, Lance, Howard; PARRISH, Cynthia, Ann Patent: WO2013/28445 A1, 2013 ; |
|
~%
270912-72-6 |
| Literature: GLAXOSMITHKLINE LLC; DOCK, Steven, Thomas; MCSHERRY, Allison, K.; MOORE, Michael, Lee; RIDGERS, Lance, Howard; PARRISH, Cynthia, Ann Patent: WO2013/28445 A1, 2013 ; |
|
~%
270912-72-6 |
| Literature: MANNKIND CORPORATION; TOLERO PHARMACEUTICALS, INC.; ZENG, Qingping; FARIS, Mary; MOLLARD, Alexis; WARNER, Steven L.; FLYNN, Gary A. Patent: WO2014/52365 A1, 2014 ; |
| Precursor 10 | |
|---|---|
| DownStream 2 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |